封面
市場調查報告書
商品編碼
1446459

顱內動脈瘤市場規模、佔有率、趨勢分析報告:按類型、最終用途、按地區、細分市場趨勢:2024-2030

Intracranial Aneurysm Market Size, Share & Trends Analysis Report By Type, (Surgical Clipping, Endovascular Coiling, Flow Diverters), By End-use, By Region, And Segment Forecasts, 2024 - 2030

出版日期: | 出版商: Grand View Research | 英文 137 Pages | 商品交期: 2-10個工作天內

價格

顱內動脈瘤市場成長與趨勢:

Grand View Research, Inc.最新報告顯示,預計到2030年,全球顱內動脈瘤市場規模將達到23.3億美元,2023年至2030年複合年成長率為9.08%。

市場的成長歸因於多種因素,例如中風病例增加、腦血管意外發病率增加以及主要企業不斷推出產品。它在新興市場也迅速成長,這些市場的可支配收入水準有所提高,獲得醫療保健的機會也有所改善。目前,腦動脈瘤的病因尚不清楚。然而,與這種情況相關的因素有很多,包括老齡化、腦外傷、遺傳、高血壓、動脈硬化、感染疾病和久坐的生活方式。顯著的症狀包括腦神經功能障礙、局部頭痛和複視。

因此,受顱內動脈瘤影響的人數不斷增加,促進了市場的擴張。該領域的公司不斷尋找讓現有治療方法更安全、更有效的方法,同時引入新技術,這將增加全球對顱內動脈瘤產品的需求,這是可預期的。例如,2022年6月,印度美敦力公司開發了具有CE標誌的第四代流路偏轉器“Pipeline Vantage with Shield Technology”,用於腦動脈瘤的血管內治療。 Pipeline Vantage是一種新開發的導流器,配備了屏蔽技術,增強了輸送系統和植入的設計特性。透過開發一種促進目標血管最內層細胞發育的支架,我們將使醫生更容易、更可靠地輸送、部署和修復腦動脈瘤和顱內動脈瘤。

顱內動脈瘤市場報告亮點

  • 2023年,血管內卷取圈佔據市場主導地位,佔有率為84.6%。這是由於它在微創神經外科中的應用不斷增加,並且可以輕鬆訪問偏遠地區的多個動脈瘤。
  • 2023年,醫院終端用途細分收益佔有率最大,為89.52%。顱內動脈瘤手術是最複雜的手術之一,依賴醫院提供的高品質和耐用的設備。
  • 北美在2023年佔據市場主導地位,佔有率為26.65%。該市場競爭激烈,現有企業和新興企業都尋求透過產品創新、併購、收購和合作來獲得行業佔有率。
  • 因此,北美主要企業的存在預計將推動該地區的市場成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章顱內動脈瘤市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 顱內動脈瘤市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • 價格分析

第4章顱內動脈瘤市場:類型估計和趨勢分析

  • 類型市場佔有率,2023 年和 2030 年
  • 細分儀表板
  • 按類型分類的全球顱內動脈瘤市場展望
  • 2018年至2030年市場規模、預測與趨勢分析
    • 腦動脈夾閉術
    • 彈簧圈栓塞
    • 分流器
    • 其他

第5章顱內動脈瘤市場:最終用途估計與趨勢分析

  • 2023 年及 2030 年最終用途市場佔有率
  • 細分儀表板
  • 以最終用途分類的全球顱內動脈瘤市場展望
  • 2018年至2030年市場規模、預測與趨勢分析
    • 醫院
    • 診所
    • 其他

第6章顱內動脈瘤市場:區域估計與趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 2018-2030年市場規模及預測趨勢分析:
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商形勢
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2023
    • Medtronic plc
    • Stryker Corporation
    • MicroPort Scientific Corporation.
    • Johnson &Johnson Services, Inc.
    • MicroVention Inc.
    • B. Braun Melsungen AG
    • Integra LifeSciences
    • RAUMEDIC AG
    • Terumo Corporation
    • Delta Surgical
Product Code: GVR-4-68038-416-1

Intracranial Aneurysm Market Growth & Trends:

The global intracranial aneurysm market size is anticipated to reach USD 2.33 billion by 2030, registering a CAGR of 9.08% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to various factors, such as increased cases of stroke, increasing incidence of people suffering from cerebrovascular disorders, and continuous product launches by key players. Furthermore, the market is growing rapidly in developing nations with expanding disposable income levels and improved access to healthcare. Currently, the cause of brain aneurysms is not clearly understood. However, there are various factors linked to this condition, including aging, brain trauma, hereditary, high blood pressure, atherosclerosis, infections, and a sedentary lifestyle. Notable symptoms encompass cranial nerve dysfunction, localized headaches, and double vision.

Consequently, the growing population of individuals afflicted with intracranial aneurysms is contributing to the market expansion. Businesses in this field are always looking for ways to make existing therapies safer and more effective while also introducing new technologies, which are anticipated to increase the demand for intracranial aneurysm products globally. For instance, in June 2022, Pipeline Vantage with Shield Technology, a fourth-generation flow deflector with a CE mark by India Medtronic, was developed for endovascular therapy for cerebral aneurysms. A newly developed flow deflector, Pipeline Vantage, features Shield technology and has enhanced features of the design for both the delivery system and the implant. By developing a scaffold that promotes the development of cells in the innermost layer of the target blood vessel, these qualities make it easier and more reliable for doctors to deliver, deploy, and repair brain aneurysms and intracranial aneurysms.

Intracranial Aneurysm Market Report Highlights:

  • In 2023, the endovascular coiling segment dominated the market with a share of 84.6%due to its increasing application in minimally invasive neurosurgeries and easy access to multiple aneurysms in distant areas
  • The hospitals end-use segment held the largest revenue share of 89.52% in 2023. Intracranial aneurysm procedures are among the most complicated surgeries that are dependent on high-quality and durable equipment available in hospitals
  • North America dominated the market with a share of 26.65% in 2023. The market is competitive, with both established companies and emerging players striving to capture higher industry share through product innovations, mergers, acquisitions, and partnerships
  • Thus, the presence of key players in North America is expected to boost the regional market growth

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End-use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type
    • 2.2.2. End-use
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Intracranial aneurysm Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing incidence of neurological diseases
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Increasing preference for targeted therapy approach
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Risk of DBS surgery
      • 3.2.2.2. Complex regulatory framework
  • 3.3. Intracranial aneurysm Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Pricing Analysis
    • 3.3.3. Pricing Analysis

Chapter 4. Intracranial aneurysm Market: Type Estimates & Trend Analysis

  • 4.1. Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Intracranial aneurysm Market by Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Surgical Clipping
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Endovascular Coiling
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Flow Diverters
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Intracranial aneurysm Market: End-use Estimates & Trend Analysis

  • 5.1. End-use Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Intracranial aneurysm Market by End-use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Hospitals
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 5.4.2. Clinics
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Others
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Intracranial aneurysm Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/ reimbursement structure
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/ reimbursement structure
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/ reimbursement structure
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Mexico
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.3. Argentina
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/ reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/ reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/ reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework/ reimbursement structure
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Medtronic plc
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Type benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Stryker Corporation
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Type benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. MicroPort Scientific Corporation.
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Type benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Johnson & Johnson Services, Inc.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Type benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. MicroVention Inc.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Type benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. B. Braun Melsungen AG
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Type benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Integra LifeSciences
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Type benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. RAUMEDIC AG
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Type benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Terumo Corporation
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Type benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Delta Surgical
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Type benchmarking
      • 7.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Intracranial aneurysm market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 4 North America Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 U.S. Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 6 U.S. Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Canada Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 8 Canada Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Europe Intracranial aneurysm market, by region, 2018 - 2030 (USD Million)
  • Table 10 Europe Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 11 Europe Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Germany Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 13 Germany Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 UK Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 15 UK Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 France Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 17 France Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Italy Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 19 Italy Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Spain Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 21 Spain Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Denmark Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 23 Denmark Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Sweden Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 25 Sweden Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Norway Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 27 Norway Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific Intracranial aneurysm market, by region, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 China Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 32 China Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Japan Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 34 Japan Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 India Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 36 India Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 South Korea Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 38 South Korea Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 Australia Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 40 Australia Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Thailand Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 42 Thailand Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Latin America Intracranial aneurysm market, by region, 2018 - 2030 (USD Million)
  • Table 44 Latin America Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 45 Latin America Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Brazil Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 47 Brazil Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Mexico Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 49 Mexico Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Argentina Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 51 Argentina Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 MEA Intracranial aneurysm market, by region, 2018 - 2030 (USD Million)
  • Table 53 MEA Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 54 MEA Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 South Africa Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 56 South Africa Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 UAE Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 60 UAE Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 62 Kuwait Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Intracranial aneurysm market: market outlook
  • Fig. 14 Intracranial aneurysm competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Intracranial aneurysm market driver impact
  • Fig. 20 Intracranial aneurysm market restraint impact
  • Fig. 21 Intracranial aneurysm market strategic initiatives analysis
  • Fig. 22 Intracranial aneurysm market: Type movement analysis
  • Fig. 23 Intracranial aneurysm market: Type outlook and key takeaways
  • Fig. 24 Surgical Clipping market estimates and forecast, 2018 - 2030
  • Fig. 25 Endovascular Coiling market estimates and forecast, 2018 - 2030
  • Fig. 26 Flow Diverters market estimates and forecast, 2018 - 2030
  • Fig. 27 Others market estimates and forecast, 2018 - 2030
  • Fig. 28 Intracranial aneurysm market: End-use movement analysis
  • Fig. 29 Intracranial aneurysm market: End-use outlook and key takeaways
  • Fig. 30 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 31 Clinics market estimates and forecasts,2018 - 2030
  • Fig. 32 Others market estimates and forecasts,2018 - 2030
  • Fig. 33 Global Intracranial aneurysm market: Regional movement analysis
  • Fig. 34 Global Intracranial aneurysm market: Regional outlook and key takeaways
  • Fig. 35 Global Intracranial aneurysm market share and leading players
  • Fig. 36 North America market share and leading players
  • Fig. 37 Europe market share and leading players
  • Fig. 38 Asia Pacific market share and leading players
  • Fig. 39 Latin America market share and leading players
  • Fig. 40 Middle East & Africa market share and leading players
  • Fig. 41 North America market estimates and forecasts, 2018 - 2030
  • Fig. 42 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 43 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 44 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 45 UK market estimates and forecasts, 2018 - 2030
  • Fig. 46 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 47 France market estimates and forecasts, 2018 - 2030
  • Fig. 48 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 49 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 50 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 51 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 52 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 53 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 54 China market estimates and forecasts, 2018 - 2030
  • Fig. 55 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 56 India market estimates and forecasts, 2018 - 2030
  • Fig. 57 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 58 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 59 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 60 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 61 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 62 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 63 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 64 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 65 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 66 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 67 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 68 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 69 Market share of key market players- Intracranial aneurysm market